The Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR) have extended the public comment period for the draft of their joint guidelines for the prevention, diagnosis, and treatment of Lyme disease for an additional 30 days.
The Centers for Medicare and Medicaid Services Inpatient Prospective Payment System rule for the coming fiscal year will raise reimbursements for novel antibiotics, a meaningful step in confronting the threat of infections resistant to older medicines.
IDSA, HIVMA, SHEA and PIDS call for humane, evidenced-based border policies that reflect the science and adhere to ID prevention and treatment protocols.
The World Health Organization’s declaration today that the year-long Ebola crisis is a Public Health Emergency of International Concern is hoped to raise much-needed awareness and resources for preparedness and control efforts across the region.
IDSA Board Member Dr. Helen Boucher, FIDSA, described AMR challenges, solutions to members of the House Oversight and Reform National Security subcommittee in June 26 testimony, urging lawmakers to incentivize development of new antibiotics and protect existing ones.
The Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR) have opened a public comment period for the draft of their joint guidelines for the prevention, diagnosis, and treatment of Lyme disease.
The reauthorization of the Pandemic and All Hazards Preparedness Act signed by the president Monday includes measures that are critical to ensure that our nation has the resources and expertise needed to confront, control and combat emerging public health threats.
With increased funds for important federal programs and interventions responding to infectious diseases and HIV, the health, foreign operations, and defense spending bill for fiscal year 2020 passed by the House of Representatives Wednesday reflects an understanding of a broad scope of public health threats at home and around the world, and of the resources needed to address them.
The Senate Health, Education, Labor and Pensions Committee hearing today on the Lower Health Care Costs Act provides a valuable opportunity for lawmakers to address challenges compromising access to and uptake of vaccines that are among our most important public health tools.
The Infectious Diseases Society of America announced today that it will be relocating its headquarters to 4040 Wilson Boulevard in the Ballston Quarter area of Arlington, Va., a hub of advanced research learning, technology and science in the Washington, D.C. metro area.
Uganda health officials’ confirmation today of Ebola virus among family members who travelled from the Democratic Republic of Congo brings with it the realization of a concern that has been noted since the August 2018 recognition of the current outbreak.
The Infectious Diseases Society of America (IDSA) Foundation, with generous support from Alzheimer’s Germ Quest, Inc. and The Benter Foundation is offering five, one-time $100,000 grants to researchers seeking to identify a potential infectious link to the disease.